Compare NBTX & CARG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NBTX | CARG |
|---|---|---|
| Founded | 2003 | 2005 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.6B |
| IPO Year | 2018 | 2017 |
| Metric | NBTX | CARG |
|---|---|---|
| Price | $39.35 | $33.88 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 11 |
| Target Price | $36.00 | ★ $38.32 |
| AVG Volume (30 Days) | 153.6K | ★ 806.1K |
| Earning Date | 03-31-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 675.00 |
| EPS | N/A | ★ 0.87 |
| Revenue | N/A | ★ $316,861,000.00 |
| Revenue This Year | $58.17 | $13.89 |
| Revenue Next Year | N/A | $8.91 |
| P/E Ratio | ★ N/A | $39.44 |
| Revenue Growth | N/A | ★ 59.92 |
| 52 Week Low | $8.41 | $26.39 |
| 52 Week High | $57.14 | $41.22 |
| Indicator | NBTX | CARG |
|---|---|---|
| Relative Strength Index (RSI) | 48.30 | 40.25 |
| Support Level | $36.98 | $32.67 |
| Resistance Level | $41.06 | $36.46 |
| Average True Range (ATR) | 2.95 | 1.10 |
| MACD | -0.29 | -0.40 |
| Stochastic Oscillator | 15.87 | 7.03 |
Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.
CarGurus Inc is a company that acts as an online automotive marketplace connecting buyers and sellers of new and used cars. It provides three types of marketplace Listing products, Restricted Listings, and Enhanced or Featured Listings, through which it offers real-time and historical data analyzing the connections and pricing analysis. The listing platforms offer auto manufacturers and others to buy advertising on the company's site and target consumers based on the make, model, and zip code of the cars. The company operates through two segments, namely U.S. Marketplace and Digital Wholesale. It generates maximum revenue from the U.S. Marketplace segment. Geographically, the company derives its key revenue from the United States and the rest from international markets.